AI agent crawlers now need permission. Here’s how to get it July 13, 2026 notoxpengz@gmail.com AI agent crawlers, the bots that fetch pages in real time on behalf of a person waiting for an answer, will be blocked by default on a slice of the…
How to shrink the token budget without shrinking the team July 10, 2026 notoxpengz@gmail.com Jensen Huang has a test for whether an engineer is worth keeping, and it comes with a token budget attached. Speaking on the All-In Podcast at the close of GTC…
AWS GraphRAG deployment cuts drug research cycles by 87% July 9, 2026 notoxpengz@gmail.com A recent AWS GraphRAG deployment reduced drug research and development cycles in pharmaceutical environments by 87 percent. This acceleration is achieved by integrating previously separated proprietary databases into a unified…
NHS AI blood test could reduce invasive womb cancer checks July 9, 2026 notoxpengz@gmail.com Several NHS hospitals are preparing to use an AI-powered blood test to help assess women referred for possible womb cancer before invasive checks are carried out. According to The Guardian,…
Insilico Medicine advances AI drug for IPF to Phase III trials July 7, 2026 notoxpengz@gmail.com Insilico Medicine is advancing to Phase III human trials for testing a drug identified by AI targeting idiopathic pulmonary fibrosis (IPF). This progression supplies the computational drug discovery sector with…
L’Oreal, Mondelez, and Nestle use AI to speed product development July 7, 2026 notoxpengz@gmail.com L’Oreal is using AI to shorten product development timelines and identify new uses for ingredients already present in its portfolio. The French cosmetics group has applied AI in its laboratories…
China’s AI companion rules: what Beijing is really going after July 6, 2026 notoxpengz@gmail.com An AI companion sounds dystopian, but it has become a common thread in the wider conversation about the perils of generative AI. What it refers to is essentially a conversational…
Takeda signs US$600M AI drug discovery deal with Insilico July 3, 2026 notoxpengz@gmail.com Takeda has entered a strategic collaboration with Hong Kong-based Insilico Medicine to use AI in early-stage drug discovery across the Japanese pharmaceutical company’s therapeutic areas. The companies did not disclose…
NVIDIA BioNeMo accelerates Anthropic Claude Science July 2, 2026 notoxpengz@gmail.com Anthropic Claude Science now integrates the NVIDIA BioNeMo Agent Toolkit to accelerate computational life sciences research. Anthropic has launched the public beta of Claude Science, an AI workbench built for…
Deploying retail AI to scale personalisation and customer insight July 1, 2026 notoxpengz@gmail.com Optimising retail AI infrastructure drives the successful deployment of personalisation systems and real-time customer insight. Leaders are replacing static customer interaction patterns with data pipelines capable of modifying the user…